Off-Label Use of Atypical AntipsychoticsCause for Concern?

被引：0
作者：
Andrew McKean
Erik Monasterio
机构：
[1] The Princess Margaret Hospital,Pharmacy Department
[2] Hillmorton Hospital,Medlicott Academic Unit
来源：
CNS Drugs | 2012年 / 26卷
关键词：
Major Depressive Disorder; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Licensed indications for medicines were designed to regulate the claims that can be made about a medicine by a pharmaceutical company. Off-label prescribing (i.e. prescribing a drug for an indication outside of that for which it is licensed) is legal and an integral part of medical practice. In psychiatry, off-label prescribing is common and gives clinicians scope to treat patients who are refractory to standard therapy or where there is no licensed medication for an indication. However, efficacy or safety of such off-label use may not be established.
引用
收藏
页码：383 / 390
页数：7
相关论文
共 50 条
  • [1] Off-label atypical antipsychotic use could be deadly
    Reactions Weekly, 2005, 1047 (1) : 3 - 3
  • [2] Off-Label indications for atypical antipsychotics: a systematic review
    KN Fountoulakis
    I Nimatoudis
    A Iacovides
    G Kaprinis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [3] Off-label use of atypical antipsychotics in personality disorders
    Rosenbluth, Michael
    Sinyor, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (11) : 1575 - 1585
  • [4] Off-label use of atypical antipsychotics: Lack of evidence for their use in primary insomnia
    Park, Susie H.
    FORMULARY, 2013, 48 (11) : 361 - 376
  • [5] Off-Label Use of Sodium Valproate for Schizophrenia
    Horowitz, Einav
    Bergman, Lisa Carroll
    Ashkenazy, Charna
    Moscona-Hurvitz, Irit
    Grinvald-Fogel, Haya
    Magnezi, Racheli
    PLOS ONE, 2014, 9 (03):
  • [6] Antipsychotic off-label use in the 21st century: An enduring public health concern
    Verdoux, Helene
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2025, 27 (01) : 1 - 12
  • [7] “Off-Label Use” of Second Generation Antipsychotics in an Austrian Inpatient Population — Data from the Austrian AMSP
    A. Konstantinidis
    U. Moser
    A. Kutzelnigg
    R. Grohmann
    R. Engel
    S. Kasper
    Drug Safety, 2008, 31 : 885 - 885
  • [8] Patterns of Quetiapine Use in Psychiatric Inpatients: An Examination of Off-Label Use
    Philip, Noah S.
    Mello, Kerry
    Carpenter, Linda L.
    Tyrka, Audrey R.
    Price, Lawrence H.
    ANNALS OF CLINICAL PSYCHIATRY, 2008, 20 (01) : 15 - 20
  • [9] Off-Label Use of Second Generation Antipsychotics in an Austrian Inpatient Population - Data from the Austrian AMSP
    Konstantinidis, A.
    Moser, U.
    Kutzelnigg, A.
    Grohmann, R.
    Engel, R.
    Kasper, S.
    DRUG SAFETY, 2008, 31 (10) : 952 - 953
  • [10] Off-Label Use of Second Generation Antipsychotics in Psychiatric Inpatients - Data from the AMSP Study Group
    Konstantinidis, A.
    Kutzelnigg, A.
    Moser, U.
    Grohmann, R.
    Jaquenoud Sirot, E.
    Engel, R.
    Kasper, S.
    DRUG SAFETY, 2008, 31 (10) : 926 - 926
12345